Access Bio, Inc. (KOSDAQ:950130)
5,260.00
-70.00 (-1.31%)
Aug 14, 2025, 3:30 PM KST
Access Bio Market Cap
Access Bio has a market cap or net worth of 185.01 billion as of September 19, 2025. Its market cap has decreased by -15.56% in one year.
Market Cap
185.01B
Enterprise Value
-163.29B
Revenue
74.42B
Ranking
n/a
PE Ratio
n/a
Stock Price
5,260.00
Market Cap Chart
Since May 30, 2013, Access Bio's market cap has decreased from 269.10B to 185.01B, a decrease of -31.25%. That is a compound annual growth rate of -3.02%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Aug 14, 2025 | 185.01B | 1.35% |
Dec 30, 2024 | 182.55B | -39.72% |
Dec 28, 2023 | 302.84B | -26.91% |
Dec 29, 2022 | 414.36B | -27.26% |
Dec 30, 2021 | 569.63B | -27.38% |
Dec 30, 2020 | 784.36B | 1,061.10% |
Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Samsung Biologics | 72.60T |
Celltrion | 37.10T |
ALTEOGEN | 25.28T |
Yuhan | 8,693.59B |
SK Biopharmaceuticals | 8,410.84B |
Peptron | 6,744.58B |
PharmaResearch | 6,431.19B |
ABL Bio | 5,452.05B |